News

Molecular basis for interaction between an essential protein complex and its regulator

Leah Mann
By Leah Mann
June 4, 2023

The labs of Lauren Jackson, associate professor of biological sciences and biochemistry, and Todd Graham, Stevenson Professor of Biological Sciences at the College of Arts and Science and professor of cell and developmental biology, recently published a study in the Journal of Cell Biology describing a significant interaction between an essential protein complex used for protein and lipid transport—the COPI complex—and its regulator protein.

The authors include Betty Xie and Cameron Cohen, two graduate students in the Jackson lab, and Swapneeta Date, senior scientist in the Graham lab. Together, the two groups established how COPI interacts with the regulator protein Glo3, a member of the ArfGAP protein family of enzymes. Disruptions of the interaction between COPI and Glo3 lead to deleterious effects in cells.

We sat down with Jackson to find out more about this research.

Lauren Jackson
Lauren Jackson

What issue/problem does your research address?

Our lab studies the cellular “FedEx system” that allows proteins and lipids to move between membrane-bound compartments. This work focused on COPI, which is required in all eukaryotes. Mutations in COPI are associated with multiple human diseases, including cancers and microcephalies, which are conditions in which a patient’s head is abnormally small. Pathogens, including viruses like SARS-CoV-2, also hijack COPI to take over cells.

While the field has previously established that molecules in the ArfGAP family affect COPI function, the mechanisms involved in this interaction have not been well understood. We sought to determine the basis for the interaction between COPI subunits and a specific ArfGAP protein, Glo3.

What was unique about your approach to the research?

We undertook a multi-disciplinary approach to address these questions using biochemistry, biophysics, computational artificial intelligence-based modeling, and in vivo approaches including fluorescence imaging in budding yeast. This combination of approaches allows us to use the molecular information generated from biochemical, biophysical, and computational studies to design hypotheses that could be used to test function directly in budding yeast, our model organism.

What were your findings?

We discovered a molecular “code” that explains how COPI recruits ArfGAP proteins. We identified specific amino acid residues on each protein that mediate the interaction between COPI and ArfGAP. We then tested how breaking the interaction affected the movement of transmembrane protein cargo using budding yeast as our model organism. Breaking this interaction specifically disrupted the shape of a key organelle called the Golgi, and it also misdirected specific cargo proteins to the wrong cellular location.

Figure 5 from the paper “An interaction between β′-COP and the ArfGAP, Glo3, maintains post-Golgi cargo recycling” shows β9-COP is a molecular platform on Golgi membranes.
Figure 5 from the paper “An interaction between β′-COP and the ArfGAP, Glo3, maintains post-Golgi cargo recycling” shows β9-COP is a molecular platform on Golgi membranes.

What do you hope will be achieved with the research results in the short and long terms?

Overall, many of these proteins are strongly conserved across species, which suggests our results will be relevant to human biology. This study provides a variety of molecular tools that we can use to dissect these important cellular events that drive essential membrane trafficking—the process of moving proteins and other molecules throughout the cell using membrane-bound vesicles.

What are the benefits of this research?

This research contributes to our understanding of fundamental biological processes in cellular sorting. Obtaining molecular information allows us to probe complex cellular sorting pathways so that we can understand human physiology and what goes wrong in disease states, such as in neurological disorders or cancers, when essential proteins are mutated or lost

Where is this research taking you next?

This work builds on our ongoing collaboration with Todd Graham’s lab. Together, the Jackson and Graham labs use a variety of methods to understand how the COPI/Glo3 interaction drives specific cellular sorting events (Jackson lab) and how the interaction is affected by post-translational modifications and sorting of SNAREs, a family of proteins that play essential roles in vesicle fusion events (Graham lab).

This article was written for Vanderbilt University’s School of Medicine Basic Sciences and was republished with permission. Read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Leah Mann
Leah Mann

Leah Mann is a neuroscience Ph.D. candidate at Vanderbilt University, where she studies Parkinson’s disease. She enjoys communicating her research and science at large to others and making it relatable and understandable to people outside the field.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.